Sequential HIV Therapy in Treatment Resistant HIV-1 Infected Patients
Status:
Terminated
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
This is an open label, crossover pilot study to explore the safety and efficacy of a rapid
cycling regimen of antiretroviral combination therapy in HIV-1 infected patients with virus
harboring genotypic resistance to at least three classes of antiretroviral therapy.
Phase:
Phase 4
Details
Lead Sponsor:
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)